Document is current
Any future updates will be listed below
-
Authors
Gjerde, Cecilie https://orcid.org/0000-0002-7581-6413
Mustafa, Kamal
Hellem, Sølve
Rojewski, Markus
Gjengedal, Harald
Yassin, Mohammed Ahmed
Feng, Xin
Skaale, Siren
Berge, Trond
Rosen, Annika
Shi, Xie-Qi
Ahmed, Aymen B.
Gjertsen, Bjørn Tore
Schrezenmeier, Hubert
Layrolle, Pierre
-
Funding
Funding for this research was provided by:
Reborne, Seventh Framework, European Union (241879)
- License Information
-
More Information
Article History
Received: 19 March 2018
Revised: 1 July 2018
Accepted: 6 July 2018
First Online: 9 August 2018
Ethics approval and consent to participate
: This study conforms with the Declaration of Helsinki, and was approved by the Norwegian ethical committee (2013/1284/REK Vest, University of Bergen) and by the Norwegian Medicines Agency (13/12062-15; EudraCT 2012-003139-50). The clinical trial followed the European guidelines for advanced therapeutic medicinal products (, NCT 02751125,).All patients consented to participate in the clinical trial and to publish the data.
: All authors consented to publication of this manuscript.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
